Procedures · Platelets before central line insertion
PACER randomised trial
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia
PACER trial design and results
Design
Multicentre randomised non-inferiority trial
Treatment
No prophylactic platelet transfusion before central venous catheter placement
Control
Prophylactic platelet transfusion
Population
338 patients with a platelet count of 10,000 to 50,000 per cubic millimetre, contributing 373 catheter placements
Follow-up
24 hours after placement
Primary endpoint
Catheter-related bleeding of grade 2 to 4
Result
Catheter-related bleeding of grade 2 to 4 occurred in 9 of 188 (4.8%) in the transfusion group and more often in the no-transfusion group, failing to meet the predefined non-inferiority margin.
Secondary endpoints
Grade 3 to 4 bleeding, transfusion reactions, cost
The withholding of prophylactic platelet transfusion before CVC placement in patients with a platelet count of 10,000 to 50,000 per cubic millimeter did not meet the predefined margin for noninferiority.
The trial authors, in the published abstract
How it has aged
A de-implementation trial that failed, which is worth as much as one that succeeds. Prophylactic platelets before central access in this platelet range stay.
Publications
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia
van Baarle FLF, van de Weerdt EK, van der Velden WJFM, et al. Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia. N Engl J Med 2023 May 25;388(21):1956-1965.
Non-inferiority not met for withholding platelet transfusion
More catheter-related bleeding without prophylaxis